• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

SFRP1

Mutations of tumor suppressor gene deregulate Ras-mediated signaling, which confers the

February 10, 2018 by Katherine Lewis Leave a Comment

Mutations of tumor suppressor gene deregulate Ras-mediated signaling, which confers the predisposition for developing benign or malignant tumors. abnormality of which causes the development of peripheral nerve tumors consisting 60C85% Schwann cells and 10C20% fibroblasts with small amounts of pericytes, perineurial cells, mast cells, endothelial and easy muscle mass cells.12-15 Some of NF1 patients develop … [Read more…]

Posted in: Blogging Tagged: 148849-67-6 IC50, SFRP1

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by